← FDA ENFORCEMENT
F-0907-2024Class II

The Procter & Gamble Company

Recalling firm
The Procter & Gamble Company
Product type
Food / supplement / cosmetic
Status
Terminated
Report date
2024-02-28
Distribution
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin
Firm state
OH
Product quantity
21,428 cases TOTAL
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Documentation & Change Control
Reason for recall

Illegible Label

Product description

Meta Psyllium Fiber Capsules packaged as 100 count or 160 count PET bottles - 12 bottles per case.

Code / lot info

Lot Codes (100 count): 31661725G1, 32151725G1, 324211725G1, 32481725G1, 32611725G1, 32901725G1, 33131725G1, 33311725G1, 33411725G1, 33451725G1 Product No (100 count): 80374550 Case UPC (100count): 10037000405143 Item UPC (100 count): 037000405146 Expiration Dates (100 count): 05/31/2026, 06/30/2026, 07/31/2026, 08/31/2026, 09/30/2026, 10/31/2026 Lot Codes(160 count): 31651725G2, 32171725G1, 32211725G1, 32411725G1, 32581725G, 32771725G1, 32911725G3, 32961725G1, 33171725G1, 33251725G2, 33451725G2 Product No. (160 count) 80374554 Case UPC (160 count): 10037000405112 Item UPC (16 count): 037000405115 Expiration Dates(for 160 count): 05/30/2026, 06/30/2026, 08/31/2026, 09/30/2026, 10/31/2026

Other recalls SPEQ maps to Documentation & Change Control
2026-07-22Class IIDaavlin Distributing Company2026-07-22Class ID'Dioses Fruit Pops, Inc.2026-07-22Class ID'Dioses Fruit Pops, Inc.2026-07-22Class IIChocolate Bar Holdings LLC
See all Documentation & Change Control recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.